BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

952 related articles for article (PubMed ID: 19579175)

  • 21. Circadian rhythmicity and the pharmacologic management of insomnia.
    Richardson GS; Mitrzyk BM; Bramley TJ
    Am J Manag Care; 2007 Nov; 13(5 Suppl):S125-8. PubMed ID: 18041873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Melatonin receptor agonist].
    Uchiyama M
    Nihon Rinsho; 2015 Jun; 73(6):1017-22. PubMed ID: 26065135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Circadian rhythm sleep disorders].
    Pallesen S; Bjorvatn B
    Tidsskr Nor Laegeforen; 2009 Sep; 129(18):1884-7. PubMed ID: 19844284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melatonin: pharmacological aspects and clinical trends.
    Rios ER; VenĂ¢ncio ET; Rocha NF; Woods DJ; Vasconcelos S; Macedo D; Sousa FC; Fonteles MM
    Int J Neurosci; 2010 Sep; 120(9):583-90. PubMed ID: 20707632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melatonin and sleep disorders associated with intellectual disability: a clinical review.
    Sajith SG; Clarke D
    J Intellect Disabil Res; 2007 Jan; 51(Pt 1):2-13. PubMed ID: 17181598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Melatonin as a regulator of human sleep and circadian systems].
    Mishima K
    Nihon Rinsho; 2012 Jul; 70(7):1139-44. PubMed ID: 22844795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tasimelteon: A Review in Non-24-Hour Sleep-Wake Disorder in Totally Blind Individuals.
    Keating GM
    CNS Drugs; 2016 May; 30(5):461-8. PubMed ID: 27003694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A practical approach to circadian rhythm sleep disorders.
    Bjorvatn B; Pallesen S
    Sleep Med Rev; 2009 Feb; 13(1):47-60. PubMed ID: 18845459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement.
    Hughes RJ; Sack RL; Lewy AJ
    Sleep; 1998; 21(1):52-68. PubMed ID: 9485533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and Treatment of Non-24-h Sleep-Wake Disorder in the Blind.
    Emens JS; Eastman CI
    Drugs; 2017 Apr; 77(6):637-650. PubMed ID: 28229310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidepressant action of melatonin in the treatment of Delayed Sleep Phase Syndrome.
    Rahman SA; Kayumov L; Shapiro CM
    Sleep Med; 2010 Feb; 11(2):131-6. PubMed ID: 20044310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melatonin and Melatonin Agonists as Adjunctive Treatments in Bipolar Disorders.
    Geoffroy PA; Etain B; Franchi JA; Bellivier F; Ritter P
    Curr Pharm Des; 2015; 21(23):3352-8. PubMed ID: 26088111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tasimelteon approved for circadian disorder in blind adults.
    Traynor K
    Am J Health Syst Pharm; 2014 Mar; 71(5):350. PubMed ID: 24534583
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative Review of Approved Melatonin Agonists for the Treatment of Circadian Rhythm Sleep-Wake Disorders.
    Williams WP; McLin DE; Dressman MA; Neubauer DN
    Pharmacotherapy; 2016 Sep; 36(9):1028-41. PubMed ID: 27500861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of chronobiotics in the resynchronization of the sleep-wake cycle.
    Cardinali DP; Furio AM; Reyes MP; Brusco LI
    Cancer Causes Control; 2006 May; 17(4):601-9. PubMed ID: 16596316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The human circadian system in normal and disordered sleep.
    Richardson GS
    J Clin Psychiatry; 2005; 66 Suppl 9():3-9; quiz 42-3. PubMed ID: 16336035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melatonin treatment for insomnia in pediatric patients with attention-deficit/hyperactivity disorder.
    Bendz LM; Scates AC
    Ann Pharmacother; 2010 Jan; 44(1):185-91. PubMed ID: 20028959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melatonin for primary insomnia?
    Drug Ther Bull; 2009 Jul; 47(7):74-7. PubMed ID: 19567841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical assessment of drug-drug interactions of tasimelteon, a novel dual melatonin receptor agonist.
    Ogilvie BW; Torres R; Dressman MA; Kramer WG; Baroldi P
    J Clin Pharmacol; 2015 Sep; 55(9):1004-11. PubMed ID: 25851638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circadian rhythm sleep disorders in the blind and their treatment with melatonin.
    Skene DJ; Arendt J
    Sleep Med; 2007 Sep; 8(6):651-5. PubMed ID: 17420154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.